载脂蛋白H在抗磷脂抗体综合症中作用的细胞与分子机理

基本信息
批准号:39970703
项目类别:面上项目
资助金额:10.00
负责人:蔡国平
学科分类:
依托单位:清华大学
批准年份:1999
结题年份:2002
起止时间:2000-01-01 - 2002-12-31
项目状态: 已结题
项目参与者:王少雄,马红,关钧,吕义晟,李国富,龙英
关键词:
抗磷脂抗体综合症载脂蛋白H
结项摘要

Antiphospholipid syndromes(APS)are serious autoimmune diseases. b2-glycoprotein I (b2-GPI)or apolipoprotein H (ApoH). In recent years, interest in b2GPI increased dramatically because it has been proposed to be most clinically relevant in patients with anti-phospholipid syndrome (APS). .The present study are shown bellow:.1.To investigate polymorphisms of human serum b2-glycoprotein I in about 500 healthy Chinese and 52 APS positive by isoelectroric focusing analysis. It indicated that although for APS patient, the ApoH allele frequencities do not significantly alter, some abnormal changes of serum ApoH in gene expression and molecular structure may occur, resulting in the alteration of antigenicity..2.Anticardiolipid antibody (ACA) in APS patients' serum displayed remarkable anti-b2-GPI activity. It is proposed that the ACA-targeted antigenicity was involved in alterated b2-GPI, which might cause 'antigen-drive' immunoreaction. .3. For first time indicated that there was a Fc-binding factor in APS patients' serum, which was identified with anti-b2-GPI antibody as well as ACA..4. For first time showed that the plasma soluble protein b2-glycoprotein is a cofactor or activator of tPA to significantly augment the tPA-dependent plasminogen activation. The specific ability of b2GP can be inhibited markedly by anti-b2GP antibody and was b2GPI dose-responsive, and that the further activation by plasmin may provide a nevol positive feedback mechanism of intrinsic fibrinolysis.The complex prothrombosis and anti-coagulation in APS patient' vascular system was explained in view of this novel activation pathway of tPA-dependent plasminogen system.5. To demonstrate the importance of the formation of b2-GPI-antib2-GPI antibody-annexin II-anti annexin II antibody complex in the cellular mechanism of APS. To investigate bioenergics in apoptosis, the relation between BcL-2 gene and telomerase activities in apoptosis, the anti-apoptosis of collagen..

载脂蛋白H在抗磷脂抗体综合症的作用的研究正深刻影响对这一自身免疫病的认识颐墙訟PS中该蛋白结构功能的变化,抗该蛋白抗体的结构功能,该蛋白及其抗体对血苣谄は赴饔眉捌涫芴搴托畔⑼揪叮玫鞍准翱固逵肷鱿赴慕岷霞耙鸬南赴峁构δ艿母谋湔馑姆矫婵寡芯浚酉赴肿铀缴仙罨韵喙刈陨砻庖卟〉娜鲜恫⒂幸嬗诹俅彩导

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

小跨高比钢板- 混凝土组合连梁抗剪承载力计算方法研究

小跨高比钢板- 混凝土组合连梁抗剪承载力计算方法研究

DOI:10.19701/j.jzjg.2015.15.012
发表时间:2015
2

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

DOI:10.1080/15476286.2017.1377868.
发表时间:2017
3

Engineering Leaf-Like UiO-66-SO_3H Membranes for Selective Transport of Cations

Engineering Leaf-Like UiO-66-SO_3H Membranes for Selective Transport of Cations

DOI:10.1007/s40820-020-0386-6
发表时间:2020
4

Himawari-8/AHI红外光谱资料降水信号识别与反演初步应用研究

Himawari-8/AHI红外光谱资料降水信号识别与反演初步应用研究

DOI:
发表时间:2020
5

PI3K-AKT-mTOR通路对骨肉瘤细胞顺铂耐药性的影响及其机制

PI3K-AKT-mTOR通路对骨肉瘤细胞顺铂耐药性的影响及其机制

DOI:
发表时间:2021

蔡国平的其他基金

批准号:10772112
批准年份:2007
资助金额:38.00
项目类别:面上项目
批准号:39670363
批准年份:1996
资助金额:10.00
项目类别:面上项目
批准号:30270515
批准年份:2002
资助金额:19.00
项目类别:面上项目
批准号:50143011
批准年份:2001
资助金额:7.00
项目类别:专项基金项目
批准号:11772187
批准年份:2017
资助金额:66.00
项目类别:面上项目
批准号:11072146
批准年份:2010
资助金额:44.00
项目类别:面上项目
批准号:39340001
批准年份:1993
资助金额:20.00
项目类别:专项基金项目
批准号:11272202
批准年份:2012
资助金额:90.00
项目类别:面上项目
批准号:10472065
批准年份:2004
资助金额:25.00
项目类别:面上项目
批准号:39370205
批准年份:1993
资助金额:7.00
项目类别:面上项目

相似国自然基金

1

抗磷脂综合症动脉血栓发病机理研究

批准号:30371380
批准年份:2003
负责人:刘庆平
学科分类:H0805
资助金额:21.00
项目类别:面上项目
2

中性粒细胞胞外诱捕网(NETs)在抗磷脂抗体介导的胎盘源性病理妊娠中的作用机制

批准号:81873842
批准年份:2018
负责人:王谢桐
学科分类:H0417
资助金额:57.00
项目类别:面上项目
3

β2-糖蛋白I在抗磷脂抗体综合征中诱导抗体产生的机制

批准号:39570317
批准年份:1995
负责人:杨翰仪
学科分类:H0214
资助金额:6.00
项目类别:面上项目
4

抗磷脂抗体诱导中性粒细胞释放NETs致抗磷脂综合征肾病的机制研究

批准号:81671589
批准年份:2016
负责人:杨程德
学科分类:H1107
资助金额:57.00
项目类别:面上项目